Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges

Uchechukwu K.A. Sampson, Sergio Fazio, MacRae F. Linton

View at source ↗Review439 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1007/s11883-011-0219-7
Published
Nov 18, 2011
Venue
Current Atherosclerosis Reports
DOI
10.1007/s11883-011-0219-7
PubMed
22102062
Categories
Lipoproteins and Cardiovascular Health
Provenance
openalex

Topics